Article Versions Notes

Darwich A, Dally F-J, Bdeir M, Kehr K, Miethke T, Hetjens S, Gravius S, Assaf E, Mohs E. Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance. Antibiotics. 2021; 10(9):1139. https://doi.org/10.3390/antibiotics10091139

Darwich, Ali, Franz-Joseph Dally, Mohamad Bdeir, Katharina Kehr, Thomas Miethke, Svetlana Hetjens, Sascha Gravius, Elio Assaf, and Elisabeth Mohs. 2021. "Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance" Antibiotics 10, no. 9: 1139. https://doi.org/10.3390/antibiotics10091139

Darwich, A., Dally, F. -J., Bdeir, M., Kehr, K., Miethke, T., Hetjens, S., Gravius, S., Assaf, E., & Mohs, E. (2021). Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance. Antibiotics, 10(9), 1139. https://doi.org/10.3390/antibiotics10091139